FDA Device Intelligence
Home › Cefaly Technology SPRL › Cefaly®

Cefaly®

Cefaly Technology SPRL · Model Dual · UDI-DI 05425018850259

PCC Prescription
1
510(k) clearances
32
Adverse events
0
Recalls
12
Facilities

Description

The Cefaly® Dual device is indicated for: - The acute treatment of migraine with or without aura in patients 18 years of age or older. - The prophylactic treatment of episodic migraine in patients 18 years of age or older.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.